BOCA RATON, FL / ACCESSWIRE / July 7, 2020 / StemSation International, Inc. (OTC PINK:STSN) – a pioneer in the emerging category of dietary supplements called Stem Cell Nutrition, announces it has filed a Statement of Use on four separate trademarks on which the US Patent & Trademark Office has granted a Notice of Allowance.
StemSation, through its wholly-owned subsidiary, StemSation IP Holding LLC, plans to build a valuable portfolio of intellectual property, to include patents, trademarks and copyrights as it continues to successfully execute on its first-year business plan.
StemSation’s President & CEO, Ray Carter commented, “This is an important step forward in building our brand and our IP portfolio in the US market and eventually around the world. Our unique and effective products are quickly gaining consumer loyalty and healthcare practitioner support as impressive test results and testimonials are being reported back to us.”
The four trademarks include StemRCMTM, ProStem PSPTM, StemFlexTM and StemSationTM, encompassing our three initial products and all are expected to formally receive grants to be listed as Registered trademarks shortly. www.stemsation.global.
Our product line is designed to support the two most recently discovered biological systems of the human body – the stem cell system of renewal and repair, and the endocannabinoid system of regulating physiological functions in both the central and peripheral nervous system and in peripheral organs. https://www.youtube.com/watch?v=rmTyJ7xtbHM&t=31s.
StemSation is a company with a long-term ‘health mission’, ambitious research goals, and innovative, holistic approaches to health & wellness, and healthy longevity. Our product line shows a new pathway to wellness.
ABOUT STEMSATION INTERNATIONAL, INC.
StemSation International, Inc. (OTC PINK:STSN) develops, manufactures and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body through using a direct selling model in which Independent Wellness Advocates (“IWAs”) advertise and sell its products directly to consumers. StemSation is headquartered in Boca Raton, Florida and its website can be located at www.stemsation.global.
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company’s control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
FOR INFORMATION, PLEASE CONTACT:
Nicholas B. Panza, Vice-President
StemSation International, Inc.
7777 Glades Road
Boca Raton, FL 33434
SOURCE: StemSation International, Inc.
View source version on accesswire.com: